Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |